Zobrazeno 1 - 10
of 10
pro vyhledávání: '"R E Tokmachev"'
Publikováno v:
Терапевтический архив, Vol 91, Iss 3, Pp 36-41 (2019)
The aim of the study was to evaluate the ARVI prevention effectiveness in patients with chronic heart failure (CHF) using interferon inducer amixin. Materials and methods. Conducted a comprehensive survey, dynamic monitoring and treatment of 60 patie
Externí odkaz:
https://doaj.org/article/2845ee872e3b4e8289fe0a0240f0cc51
Publikováno v:
Терапевтический архив, Vol 88, Iss 9, Pp 106-110 (2016)
The review considers the main points of the concept of progressive chronic heart failure (CHF). The neurohumoral model of CHF pathogenesis could create novel approaches to treating these patients. However, recent studies have shown that the ways of a
Externí odkaz:
https://doaj.org/article/27e6793ba63b4516959ab31d97c1476a
Autor:
Y. A. Krasnikova, Ya. S. Shkatova, R. E. Tokmachev, A. Y. Kravchenko, A. V. Budnevsky, T. A. Chernik
Publikováno v:
Pakistan Journal of Medical and Health Sciences. 15:1445-1448
Thyroid gland dysfunction is a risk factor for development of cardiovascular diseases. From all types of thyroid gland dysfunction hypothyroidism is the most common. Increasing of thyroid-stimulating hormone level can influence the clinical course of
Publikováno v:
Tuberkulez i Bolezni Lëgkih, Vol 97, Iss 9, Pp 17-21 (2019)
Chronic obstructive pulmonary disease (COPD) and overweight/obesity are among the leading health problems worldwide. The objective: to conduct a comparative analysis of exercise tolerance in patients with COPD with normal body mass and overweight dur
Publikováno v:
Russian Journal of Cardiology. 27:5009
Aim. To establish the correlations of the soluble suppression of tumorigenicity 2 protein (sST2) and N-terminal pro-brain natriuretic peptide (NT-proBNP) with some clinical and paraclinical characteristics of patients with heart failure (HF).Material
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 17, Iss 6, Pp 62-68 (2018)
This article discusses the epidemiology of chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD). CHF and COPD are characterized by high prevalence and high mortality, especially when they are combined. The article analyzes the
Autor:
A. V. Budnevsky, O. S. Saurina, A. A. Natarov, R. E. Tokmachev, V. S. Nechaev, L. I. Letnikova
Publikováno v:
Problems of Social Hygiene Public Health and History of Medicine. 27
Anemia is a clinical hematological syndrome and also a risk factor for the adverse outcome of many chronic somatic diseases. To assess effectiveness of out-patient polyclinic care for patients with anemia, the computer program "Patient Monitoring Sys
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 15, Iss 4, Pp 80-83 (2016)
Regardless current achievements of medicine, chronic heart failure (CHF) is still the leading cause of cardiovascular morbidity and mortality. A special cohort in CHF mortality are patients with progressive body mass loss. Recently the assessment of
Autor:
A. V. Budnevsky, A. Ya. Kravchenko, R. E. Tokmachev, T. A. Chernik, E. V. Tokmachev, Yu. B. Letnikova
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 19, Iss 6 (2020)
The six-minute walk test (6MWT) is a well-known exercise test used in medical practice to assess the functional status of patients with various chronic cardiovascular and respiratory diseases. The results of modern research describe new potential of
Autor:
O. M. Drapkina, A. V. Kontsevaya, A. Ya. Kravchenko, A. V. Budnevskiy, R. E. Tokmachev, T. A. Chernik
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 3S (2021)
Chronic heart failure (CHF) is a pathology that affects more than 37 million people worldwide. Despite the introduction of new drugs into practice, that have proven their effectiveness in the treatment of patients with CHF, the life expectancy of the
Externí odkaz:
https://doaj.org/article/b8e89985010149fd871f9d2ddc509dda